Article
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
Strong Bullish
100.0
−100 Bearish
0
+100 Bullish
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Apr 30, 2026 · 10:32 am
Article ID
egqst7c
Original URL
Open source
Sentiment Signal
Strong Bullish
100.0
−100Neutral+100
More Like This